Get the Stockscreener App
0.288
2.86%
0.008
Virax Biolabs Group Ltd stock is traded at $0.288, with a volume of 107.72K.
It is up +2.86% in the last 24 hours and down -19.78% over the past month.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
See More
Previous Close:
$0.28
Open:
$0.28
24h Volume:
107.72K
Relative Volume:
0.02
Market Cap:
$2.09M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.0152
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
+5.49%
1M Performance:
-19.78%
6M Performance:
-69.78%
1Y Performance:
-85.95%
1-Day Range:
$0.275
$0.2899
1-Week Range:
$0.2633
$0.29
52-Week Range:
$0.255
$2.29
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.2822 | 2.08M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.04 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.43 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
844.92 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
350.35 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
348.88 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Exit Recap: Should I average down on PodcastOne Inc stockGap Down & Smart Investment Allocation Insights - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Virax Biolabs Group (NASDAQ:VRAX) Upgraded at Zacks Research - Defense World
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright By Investing.com - Investing.com South Africa
Virax Biolabs stock price target lowered to $1 at H.C. Wainwright - Investing.com India
Virax Biolabs secures $5 million in private placement to advance immunology research - MSN
HC Wainwright Reaffirms “Buy” Rating for Virax Biolabs Group (NASDAQ:VRAX) - Defense World
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target - TipRanks
VRAX Analyst Forecasts - Quiver Quantitative
Why Virax Biolabs Group Limited stock is favored by top institutions - Улправда
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - Chartmill
Virax Biolabs Releases Interim Financial Results for September 2025 - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Virax Biolabs Group Limited stock positioned for long term growthJuly 2025 Update & Real-Time Market Trend Scan - Улправда
Can Virax Biolabs Group Limited stock beat market expectations this quarterWeekly Market Outlook & Real-Time Sentiment Analysis - Улправда
Virax Biolabs (NASDAQ: VRAX) details 25.9M-share resale from $5M raise - Stock Titan
Virax Biolabs Group (NASDAQ:VRAX) Shares Down 11.3% – Here’s Why - Defense World
A new trading data show Virax Biolabs Group Ltd (VRAX) is showing positive returns. - Setenews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Penny Stocks To Keep An Eye OnDecember 3rd - MarketBeat
Why Virax Biolabs Group Limited stock is seen as undervalued2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research - The Globe and Mail
Virax Biolabs (Nasdaq: VRAX) closes $5 million raise, cash runway into 2028 - Stock Titan
US Market Preview | VRAX Surges 108.0%; ADP Jobs Data Misses Expectations, Futures Rise; NVDA's OpenAI Investment Pending - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Healthy Upside Potential: Transocean Ltd (RIG) - Setenews
Ready to Jump After Recent Trade: Virax Biolabs Group Ltd (VRAX) - setenews.com
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com UK
United States shares higher at close of trade; Dow Jones Industrial Average up 0.86% By Investing.com - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.86% - Investing.com
Scienjoy (NASDAQ: SJ): Deep-Value, Cash-Rich Tech with Mixed-Reality Upside More Inside - openPR.com
Virax Biolabs Group Limited (VRAX) Stock: Surges as 2026 Strategy and Clinical Milestones Ignite Investor Interest - parameter.io
Virax Biolabs : Announces $5 Million Private Placement - marketscreener.com
Virax Biolabs (Nasdaq: VRAX) announces $5 million private placement for working capital - Stock Titan
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BC-Most Active Stocks - Yahoo Finance
Ming Shing Group (NASDAQ: MSW) adds Tianhang Zhao to Board, audit chair named - Stock Titan
US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Benzinga
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics By Investing.com - Investing.com South Africa
Virax Biolabs stock rockets after clinical progress in post-infection diagnostics - Investing.com India
Credo Technology Group (NASDAQ: CRDO) to present at Barclays 23rd Global Technology Conference on Dec. 10 - Stock Titan
The LGL Group (NYSE American: LGL) moves warrant deadline from Dec. 9 to Dec. 16, 2025 - Stock Titan
Nu Holdings (NYSE: NU) to add Brazil banking license without changing Nubank brand - Stock Titan
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PR Newswire
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.03%
3.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):